ARCHETYPE Microscopic findings - Lymphoma (openEHR-EHR-CLUSTER.microscopy_lymphoma.v1)

Type: openEHR ARCHETYPE
Purpose: To record detailed findings about lymphoma and other haematopoietic tumours, excluding leukaemias, found on microscopic examination.
Use: To record detailed findings about microscopic examination of tissue related to lymphoma or other hameatopietic tumour, excluding leukaemias Use as a component archetype in the context of a suite of archetypes that make up a histopathology report ie OBSERVATION.lab_test.histopathology.
Misuse: Not designed to be used within any other archetype other than OBSERVATION.lab_test.histopathology. Not designed to be used to record microscopic findings for leukaemias.

Available formats: ADL XML

ARCHETYPE IDopenEHR-EHR-CLUSTER.microscopy_lymphoma.v1
ConceptMicroscopic findings - Lymphoma
DescriptionMicroscopic anatomical pathology findings related to lymphoma and other haematopoietic tumours, excluding leukaemias.
UseTo record detailed findings about microscopic examination of tissue related to lymphoma or other hameatopietic tumour, excluding leukaemias Use as a component archetype in the context of a suite of archetypes that make up a histopathology report ie OBSERVATION.lab_test.histopathology.
MisuseNot designed to be used within any other archetype other than OBSERVATION.lab_test.histopathology. Not designed to be used to record microscopic findings for leukaemias.
PurposeTo record detailed findings about lymphoma and other haematopoietic tumours, excluding leukaemias, found on microscopic examination.
ReferencesRoyal College of Pathologists of Australasia. Tumours of haematopoietic and lymphoid tissue, Structured Reporting Protocol (1st Edition 2010). [Internet]. 2010;[cited 2010 Mar 21 ] Available from: http://www.rcpa.edu.au//static/File/Asset%20library/public%20documents/Publications/StructuredReporting/TUMOURS%20OF%20HAEMATOPOIETIC%20AND%20LYMPHOID%20TISSUE%20STRUCTURED%20REPORTING%20PROTOCOL.pdf

College of American Pathologists. Lymphoma and Hodkgin disease - Full protocol [Internet]. 2005 Jan ;[cited 2009 Jul 25 ]
Available from: http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2005/lymphnonhodg05_pw.pdf
Copyrightcopyright (c) 2010 openEHR foundation
AuthorsAuthor name: Dr Ian McNicoll
Organisation: Ocean Informatics, UK
Email: ian.mcnicoll@oceaninformatics.com
Date originally authored: 26/04/2009
Other Details LanguageAuthor name: Dr Ian McNicoll
Organisation: Ocean Informatics, UK
Email: ian.mcnicoll@oceaninformatics.com
Date originally authored: 26/04/2009
Other Details (Language Independent)
  • References: Royal College of Pathologists of Australasia. Tumours of haematopoietic and lymphoid tissue, Structured Reporting Protocol (1st Edition 2010). [Internet]. 2010;[cited 2010 Mar 21 ] Available from: http://www.rcpa.edu.au//static/File/Asset%20library/public%20documents/Publications/StructuredReporting/TUMOURS%20OF%20HAEMATOPOIETIC%20AND%20LYMPHOID%20TISSUE%20STRUCTURED%20REPORTING%20PROTOCOL.pdf College of American Pathologists. Lymphoma and Hodkgin disease - Full protocol [Internet]. 2005 Jan ;[cited 2009 Jul 25 ] Available from: http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2005/lymphnonhodg05_pw.pdf
  • MD5-CAM-1.0.1: D043F085224476623B5D3D1F274898D7
Keywordslab, pathology, laboratory, lymphoma, haematopoietic, malignancy, haematology, hodgkin, histopathology, cancer, non-hodgkin
LifecycleAuthorDraft
Language useden
Citeable Identifier1013.1.349
items
Infiltration patternInfiltration pattern: Findings of pattern of abnormal cell infiltration.
Tumour cell sizeTumour cell size: Estimates of tumour cell size.
  • Small [Small or intermediate tumour cell size (smaller than a histiocyte nucleus).]
  • Medium [Medium tumour cell size (equal to a histiocyte nucleus).]
  • Large [Large tumour cell size (larger than a histiocyte nucleus).]
  • Indeterminate [The tumour cell size has not been determined.]
  • Mixed [Mixed tumour cell size.]
Proliferative indicatorsProliferative indicators: Proilerative indicators of abnormal cells.
Abnormal cytomorphologyAbnormal cytomorphology: Findings of abnormal cell morphology.
Cytomorphology findingsCytomorphology findings: Findings of generic cytomorphology.
Generic featuresGeneric features: Finding of generic cytomorphology features.
Choice of:
  •  Coded Text
    • Pleomorphic [Pleomorphic features are present.]
    • Hyperbolate [Hyperbolate features are present.]
    • Anaplastic [Anaplastic features are present.]
    • Clear cell [Clear cell features are present.]
    • Giant cell [Giant cell features are present.]
    • Spindle cell [Spindle cell features are present.]
    • Signet ring cell [Signet ring cell features are present.]
    • Blastic [Blastic features are present.]
    • Indeterminate [Generic abnormal cell features have not been determined.]
  •  Text
Specific featuresSpecific features: Finding of specific cytomorphology features.
Choice of:
  •  Coded Text
    • Centroblastic [Centroblastic features are present.]
    • Centrocytic [Centrocytic features are present.]
    • Immunoblastic [Immunoblastic features are present.]
    • Plasmacytic [Plasmacytic features are present.]
    • Lymphoplasmacytic [Lymphoplasmacytic features are present.]
    • Lymphoplasmacytoid [Lymphoplasmacytoid features are present.]
    • Prolymphocytic [Prolymphocytic features are present.]
    • Paraimmunoblastic [Paraimmunoblastic features are present.]
    • Plasmablastic [Plasmablastic features are present.]
    • Monocytoid [Monocytoid features are present.]
    • Centrocyte-like [Centrocyte-like features are present.]
    • Popcorn cell [Popcorn cell features are present.]
    • Reed-Sternberg cell-like [Reed-Sternberg cell-like cytomorphology features are present.]
    • Indeterminate [Specific cytomorphology features have not been determined.]
  •  Text
Grade (follicular lymphoma)Grade (follicular lymphoma): Histological grade - follicular lymphoma only.
  • Grade 1 [Follicular lymphoma Grade 1.]
  • Grade 2 [Follicular lymphoma Grade 2.]
  • Grade 3 [Follicular lymphoma Grade 3.]
  • Grade 3a [Follicular lymphoma Grade 3a.]
  • Grade 3b [Follicular lymphoma Grade 3b.]
Host cell/tissue reactionsHost cell/tissue reactions: Findings of host cell reactions to tumour.
Host cell reactionHost cell reaction: Finding of a host cell reaction to tumour.
Choice of:
  •  Coded Text
    • T-cell rich [T-cell rich host cell reaction is present.]
    • Eosinophil-rich [Eosinophil-rich host cell reaction is present.]
    • Histiocyte-rich [Histiocyte-rich host cell reaction is present.]
    • Neutrophil-rich [Neutrophil-rich host cell reaction is present.]
    • Plasma cell-rich [Plasma cell-rich host cell reaction is present.]
    • Erythrophagocytic [Erythrophagocytic host cell reaction is present.]
    • Indeterminate [Presence of a host cell reaction has not been determined.]
  •  Text
Host tissue reactionHost tissue reaction: Finding of host tissue reactions to tumour.
Choice of:
  •  Coded Text
    • Necrotic [Necrotic host tissue reaction is present.]
    • Sclerotic [Sclerotic host tissue reaction is present.]
    • Granulomatous [Granulomatous host tissue reaction is present.]
    • Suppurative [Suppurative host tissue reaction to tumour is present.]
    • High Endothelial Venule (HEV) hyperplasia [High Endothelial Venule (HEV) hyperplasia is present.]
    • Starry sky pattern [Starry sky pattern is present.]
    • Amyloid [Amyloid host tissue reaction is present.]
    • Increased reticulin [Increased reticulin is present.]
    • Indeterminate [Presence of a host tissue reaction has not been determined.]
  •  Text
Other contributorsKoray Atalag, University of Auckland, New Zealand
Matt Cordell, NEHTA, Australia
David Ellis, RCPA, Australia
Sam Heard, Ocean Informatics, Australia
Heather Leslie, Ocean Informatics, Australia
David McKillop, NEHTA, Australia
Cathy Richardson, NEHTA, Australia
Translators